Status:
COMPLETED
Evaluation of a Cross-sectional Coordinated, Severity Stepped, Evidence-based Care Model for Mental Disorders
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
Federal Ministry of Health, Germany
BARMER
Conditions:
Delivery of Health Care
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
This study evaluates a cross sectional, severity stepped, evidence-based care model for patients with mental disorders (RECOVER). RECOVER is a consortium of well-known institutions for the treatment ...
Detailed Description
Participants will be recruited from regular care settings (in-patient and out-patient services, general practitioners, psychotherapists) and via the RECOVER homepage. Upon fulfillment of the inclusion...
Eligibility Criteria
Inclusion
- Age ≥16 years
- insured in one of the relevant health insurances (BARMER GEK, AOK Rheinland/Hamburg, DAK Gesundheit, HEK, BKK Linde, BKK Mobil Oil, BKK Public, BKK RWE, BKK Salzgitter, BKK Technoform, BKK VerbundPlus, Continentale BKK, Heimat BKK, Salus BKK, TUI BKK, WMF Betriebskrankenkasse, IKK Classic, VIACTIV Krankenkasse)
- at least diagnosed with one of the relevant psychiatric disorders: Schizophrenic disorders (ICD-10: F20, F22, F23, F25); bipolar disorder (ICD-10: F31); major depressive disorder (ICD-10: F32, F33); anxiety disorder (ICD-10: F40, F41); obsessive compulsive disorder (ICD-10: F42); post traumatic stress disorder (ICD-10: F43.1); adjustment disorder (ICD-10: F43.2); somatoform disorder (ICD-10: F45); eating disorder (ICD-10: F50); personality disorder (ICD-10: F60, F61); attention-deficit hyperactivity disorders (ICD-10: F90);
- living in the surrounding area of the university medical center Hamburg-Eppendorf
Exclusion
- disorder belonging to ICD-10 F0 (mental disorders due to known physiological conditions) or F1 (primary disorders due to psychoactive substance use)
- severe to most severe low intelligence (previously diagnosed ICD-10: F72/F73)
- insufficient language skills
- uncorrected visual and/or hearing impairment
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2021
Estimated Enrollment :
905 Patients enrolled
Trial Details
Trial ID
NCT03459664
Start Date
March 15 2018
End Date
January 28 2021
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-eppendorf
Hamburg, Germany, 20246